• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders

    KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature

    Moms Raise the Bar for Kids Supplements
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing

    BGG Receives Patent for Saw Palmetto ID Method

    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Verdure Sciences’ Boswellia Ingredient Receives USP Verification
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing

    BGG Receives Patent for Saw Palmetto ID Method

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Verdure Sciences’ Boswellia Ingredient Receives USP Verification
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing

    BGG Receives Patent for Saw Palmetto ID Method

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Gaming and Esports Health Concerns

    Bioiberica’s DAOgest Authorized as Novel Food ingredient in EU

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Botanic Healthcare LLC

    PhytoGaia Inc

    Gencor

    American FlexPack
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Botanic Healthcare LLC

    PhytoGaia Inc

    Gencor

    American FlexPack
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Oral Solids: Market & Technology Trends

    Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.

    Oral Solids: Market & Technology Trends
    By Tim Wright, Editor, Contract Pharma03.03.21
    Oral solids continue to be the most commonly used delivery vehicle to get drugs to patients for three main reasons: they are cost-effective, relatively easy to manufacture, and most importantly, are patient-friendly.

    By the numbers, oral solid dosage (OSD) products remain the largest segment of the pharmaceutical market. The global OSD pharmaceutical formulation market is forecasted to grow from $493 billion in 2017 to $926 billion by the end of 2027, according to Future Market Insights. This represents a compound annual growth rate (CAGR) of 6.5% over the 10-year forecast period.

    In terms of New Molecular Entities (NMEs), from 2015-19, between 70% and 80% of NMEs approved by the FDA were small molecules. In 2019, 68% of the small molecules approved were delivered through oral dosages.

    “The current state of oral solid dose manufacturing is both mature—in that conventional tablet formulations and capacity exist—and immature—in that new formulation capabilities need to be developed and improved for more complex problem statements like bioavailability enhancing technologies and patient centric dosage forms like pediatric controlled release products,” said Dan Dobry, head of drug product commercial development, Lonza Pharma & Biotech. 

    OSD Growth Trends
    Perhaps the greatest impact on the OSD market has been the growth in the oncology sector. Between 2015 and 2020, clinical-stage cancer programs increased by 77% (1,642 to 2,911) and continue to dominate the landscape, which has led to roughly one-quarter of drugs currently in development worldwide being categorized as highly potent.

    This trend toward high potency is having a notable impact on the contract development and manufacturing organization (CDMO) space as the growing need for smaller scale and contained manufacturing processes poses a challenge for much of pharma’s installed capacity.

    “Many companies with candidates in these areas do not have the facilities needed to take a product from development to market, which is driving outsourcing to specialist CDMOs,” said John Ross, president at Mayne Pharma U.S. and Metrics Contract Services. “Larger contract manufacturers often sell higher production volumes and multi-site capabilities, but the trend has been towards specialist CDMOs as they often offer better continuity from development through to commercial requirements. Depth of specific expertise in applicable technologies is also imperative as it can often accelerate timelines and provide higher quality outcomes. This is critical in a market where getting it right quickly is typically far more valuable to sponsors than saving money on a per line item basis.”

    Another key trend affecting the global oral solid dose market is the rise of useability and patient compliance as a key concern for drug developers. This increasingly patient-centric approach is fueling a rapid rise in demand for modified release (MR) oral solid dose products.

    “Developers are turning to MR technology to meet their useability goals for a number of reasons,” said Torkel Gren, senior director, technology officer and strategic investments, Recipharm. “It can be used to extend the period of time that a medicine remains active in the body by maintaining therapeutic blood concentrations for longer than traditional immediate release products. It can delay action until a drug has reached a specific area, such as the small intestine, through the use of special coatings. And, it can also be harnessed to create fixed dose combinations, multi-API products, with the doses of each API designed to be released at different rates.”

    These features offer huge benefits for patients.  “They can enhance the therapeutic effect of a drug and can potentially reduce adverse side effects by delaying activity until it reaches the target area and lowering plasma peak concentration while maintaining the desired therapeutic effect,” continued Gren. “Most importantly, they can reduce the number of daily doses required, making them more user-friendly and enhancing patient compliance. These patient-centric benefits can help oral solid dose products maintain market share when compared with rival dosage forms.”

    Moving forward, amorphous solid dispersion technology will only become more sophisticated in addressing the pervasive challenge of poor bioavailability.

    According to Lonza’s Dobry, the utility of spray drying technology has been expanded through processing innovations to address highly insoluble molecules using a superheated feed system that makes many previously undruggable candidates viable as amorphous solid dispersions.

    In addition, Dobry said a significant new development in oral solid drug delivery technology is a lipid multi-particulate (LMP) platform aimed at tunable release and enablement of a range of patient centric dosage forms.

    “In this technology,” he explained, “the drug is encapsulated in a molten lipid mixture that is atomized on a spinning disk and congealed prior to collection. This technology produces 100-300 micron spherical particles with good mouth feel. The product can be encapsulated for adult populations but can also be used for pediatric and geriatric populations due to ease of swallowability. Because this process is semi-continuous, it allows for LMPs to be used in early clinical trials and into the commercial phase with a common process scale. In addition to tuning the lipid excipients for function, the LMPs can be coated for delayed release or taste-masking applications.”

    CDMO Expansions
    Over the past year, CDMOs have continued to invest in and expand their OSD development and manufacturing capabilities to meet the growing demands of the market. Some recent and notable examples follow.

    Lonza and NextPharma. In January 2021 the two companies entered an agreement for the potential sale of Lonza’s Ploermel, France and Edinburgh, U.K. sites, which produce liquid-filled hard capsules, including Licaps, and softgels for high potent and hormonal products. With this intended divestment, Lonza plans to exit both softgels and liquid-filled hard capsules for the pharma market, aside from retaining capability for feasibility studies as part of a technology selection offering. In the consumer health and nutrition space, Lonza plans to exit softgels but continue to offer Licaps-based products (lipid capsules) out of Colmar (FR), Greenwood (US) and Sagamihara (JP). Capsules, including Licaps for nutrition, remain core to Lonza’s offering and the company has recently announced an investment of $93 million to expand capsule manufacturing capacity by 30 billion capsules annually across eight sites.

    With this intended acquisition, NextPharma plans to develop and broaden its technology offering into lipid-based finished dosage forms—softgels and liquid-filled hard capsules—in addition to offering high potency capabilities and New Chemical Entity (NCE) development services. In 2020 the London-headquartered CDMO completed a $17 million investment to expand its existing capacity for manufacturing and packaging of oral solid dosage forms at its site in Goettingen, Germany. The project involved construction of a new 1,000-square-meter building on two levels, with additional production facilities on the ground floor for mixing, compression, film coating, and granulation. The expansion increased capacity at the site by 25%, equivalent to an increase in manufacturing and packaging capacity of approximately 1 billion tablets. A packaging line for blister packs was installed on the upper floor of the building, and another bottle packaging line will be added in the second quarter of 2021.

    More recently, Lonza expanded its solid form selection services based at its Bend, OR site. The added capabilities build on the SimpliFiH Solutions first-in-human services consisting of phase-appropriate drug substance and drug product development and manufacture. The solid form services offering also enhances Lonza’s capabilities to meet accelerated timelines for increasingly complex molecules.

    Metrics Contract Services. The CDMO started construction on the expansion of its novel oral solid dosage manufacturing facility expansion in Greenville, NC. The $10 million investment will add 3,760 square feet of production space to the current facility, providing added flexibility and capacity to the CDMO and its clients. The expansion consists of three new rooms: one dispensing/flex room, one tablet press room, and one flex room to accommodate the company’s growing portfolio of commercial services following sustained increase in demand from clients for high potent handling capabilities. New equipment also forms part of the investment and includes a Fette FE55 tablet press, a Bosch 720 encapsulator, which both offer containment capabilities for the safe handling of potent products, and a weigh and dispense isolator.

    CoreRx. The CDMO opened its fourth new facility, on the ICOT campus in Clearwater, FL in August 2020. The new Product Development Center includes nine R&D formulation development and R&D-scale manufacturing suites, nearly 5,000 square feet of analytical laboratory space as well as capacity for an additional 35 employees. The new 26,000 square foot space expands the capacity of CoreRx’s oral and topical dosage form development group, increasing drug product volume through several formulation technologies that include: blending, roller compaction, wet granulation, fluid bed drying, spray drying, and extrusion spheronization. This expansion gives CoreRx’s clients access to over 150,000 square feet of space at the ICOT center campus. The new facility is designed to streamline workflow and optimize product development efficiency, with analytical development, pre-formulation, and formulation development teams all collocated for optimal synergy.

    Catalent. In August 2020 Catalent unveiled plans to expand its Argentinian site in Loma Hermosa, Buenos Aires, adding more than 11,000 square feet of production space segregated and designed to handle cytotoxic and highly active products for prescription softgel manufacturing. The new facilities, scheduled to be completed in December 2021, will include two new manufacturing vessels of 40 and 300 liters, which include an automatic cleaning system and an innovative mixing device suitable for very high viscosity formulations, a capsule filling line and six drying tunnels. This will add a capacity of over 10 million doses per year to the site, which supplies products to the Latin American, U.S., and European markets.

    In other news, in June 2020 Catalent completed a $3.2 million expansion program at its consumer health manufacturing facilities in Strathroy, Canada and Sorocaba, Brazil. The expansion projects include new softgel encapsulation lines at each site, dedicated to Catalent’s Vegicaps plant-based capsule and CosmoPod twist-off capsule technologies. The increased capacity will enable Catalent to support its customers in both North and Latin America to develop products for consumers seeking all-natural and plant-based vitamins, minerals and supplements, using its Vegicaps capsule; and those looking for innovative, easy-to-use, unit-dose beauty care products, through its CosmoPod technology.

    Adare Pharmaceuticals. The clinical-stage pharmaceutical company and global provider of advanced pharmaceutical technologies acquired Orbis Biosciences of Lenexa, KS. Orbis provides enhanced technologies in a scaled, single-step manufacturing process. Its Precision Particle Fabrication technology is capable of producing uniform particles in size ranges suitable for use in injectable and oral dosage forms. Adare’s technologies include: Microcaps for taste-masking via a solvent or aqueous based coacervation process; Diffucaps that incorporates release-controlling polymers or protective coatings onto drug-layered cores, granules, or crystals; and the MMTS Multi Mini Tablet System in which functional membranes are applied to 1.0-2.0 mm cylindrical tablets to control release rates.

    ACG. Pharma/nutra manufacturing solutions provider ACG recently added another specialist division to its integrated global offering with the official inauguration of its first ACG Laboratories site—a lab for process development in Shirwal, India. The new facility is set to provide ACG’s customers and partners with a research, development, testing, and training environment dedicated to the collaborative exploration of all aspects of oral solid dosage manufacturing. The lab houses a dedicated R&D space for small-scale development, and a pilot area for scale-up and process optimization studies. It is equipped to accommodate multiple projects at a time.

    Alcami. In January 2021 the CDMO announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC. The investment will add a Gerteis Mini-Pactor roller compactor and low humidity suites to Alcami’s existing 140,000 square foot campus in Wilmington. The expansion, which is on track to be completed in the first and second quarter of 2021, respectively, adds dry granulation capabilities and increased flexibility to support moisture-sensitive processes. 


    Tim Wright is the Editor of Contract Pharma. He can be reached at TWright@RodmanMedia.com.
    Related Searches
    • Delivery & Dosage Technologies
    • Contract Manufacturing
    Related Knowledge Center
    • Contract Manufacturing
    • Delivery & Dosage Technologies
    Suggested For You
    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion
    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts
    Baltimore CBP Seizes $688k Shipment of Illegal Weight Gain Product Baltimore CBP Seizes $688k Shipment of Illegal Weight Gain Product
    Trends in the Nutraceuticals Market Trends in the Nutraceuticals Market
    Nature’s Way Launches Brain Fuel, a Cognitive Support Supplement Nature’s Way Launches Brain Fuel, a Cognitive Support Supplement
    G-Agmatine: An Innovative Solution for a Healthy Nervous System G-Agmatine: An Innovative Solution for a Healthy Nervous System
    Cellular Aging and Longevity: Ingredients for a New Age of Health Cellular Aging and Longevity: Ingredients for a New Age of Health
    Building on Steps to Improve Children’s Health Around the World Building on Steps to Improve Children’s Health Around the World
    Moms Raise the Bar for Kids Supplements Moms Raise the Bar for Kids Supplements
    Fungi Perfecti Discovers Counterfeit Imitation Products Sold on Amazon Fungi Perfecti Discovers Counterfeit Imitation Products Sold on Amazon
    Boosting Immune Health by Protecting Against Toxins with Glucarate Boosting Immune Health by Protecting Against Toxins with Glucarate
    Most Americans Want FSAs and HSAs to Cover Supplements Most Americans Want FSAs and HSAs to Cover Supplements
    Study: Prenatal Supplements Not Meeting Target Dosages Study: Prenatal Supplements Not Meeting Target Dosages
    Shaping and Leading an Industry without a Clear Regulatory Framework Shaping and Leading an Industry without a Clear Regulatory Framework
    CBD Innovation and Regulation in Canada: Background, Landscape, and the Future CBD Innovation and Regulation in Canada: Background, Landscape, and the Future

    Related Features

    • Consumer Trends | Delivery & Dosage Technologies | Dietary Supplements | Pet Nutraceuticals | Quality & Safety | Regulations | Research | Testing
      The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

      The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

      The pandemic compelled many people to add a furry friend to their family, and their spending habits demonstrate a dedication to health.
      By Sean Moloughney, Editor 05.30.23

    • Cognitive Function | Delivery & Dosage Technologies | Fatty Acids | Nutrition Bars & Snacks | Omega-3s
      ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

      ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

      Rikki Bhatti, co-founder of Unbound Snacks, is a third-generation farmer intent on giving walnuts their (relative) time in the limelight.
      By Sheldon Baker 05.26.23

    • Breaking News | Industry & Market News | Regulations
      Baltimore CBP Seizes $688k Shipment of Illegal Weight Gain Product

      Baltimore CBP Seizes $688k Shipment of Illegal Weight Gain Product

      Apetamin, which is imported from overseas, contains an antihistamine linked to serious adverse events.
      05.08.23


    • Trends in the Nutraceuticals Market

      Trends in the Nutraceuticals Market

      Lauren Samot, Head of Commercial Innovation and Product Development at Vitaquest International, shares insights nutraceutical industry trends.

    • Breaking News | Cognitive Function | Dietary Supplements | Herbs & Botanicals | Products | Vitamins
      Nature’s Way Launches Brain Fuel, a Cognitive Support Supplement

      Nature’s Way Launches Brain Fuel, a Cognitive Support Supplement

      The formula includes Cognigrape red grape extract as well as vitamins B6 and B12.
      05.03.23

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    Breaking News
    • Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    • BGG Receives Patent for Saw Palmetto ID Method
    • Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    • Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    • Verdure Sciences’ Boswellia Ingredient Receives USP Verification
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Cellular Aging and Longevity: Ingredients for a New Age of Health
    • Addressing the Plastic-Packaging Problem: Getting to Zero-Waste with Zero Compromise
    • Moms Raise the Bar for Kids Supplements
    • Building on Steps to Improve Children’s Health Around the World
    • FDA Remains Focused on Modernizing DSHEA
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Coatings World

    Latest Breaking News From Coatings World

    Boeing Starts Construction on New St. Louis Facility
    Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
    BCF Calls for Greater Urgency on REACH Impasse
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    Capitainer Releases to Market its Fully Automated Sample Handler
    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AVROBIO Sells Cystinosis Gene Therapy for $87.5 Million
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Unilever Uses AI for Product Development
    Beautycounter Names New Interim CEO
    Shaz & Kiks Available at Sephora
    Happi

    Latest Breaking News From Happi

    Covergirl Introduces Clean Fresh Yummy Gloss Collection
    Shaz and Kiks Launches at Sephora
    Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
    Ink World

    Latest Breaking News From Ink World

    ACTEGA, Makro Labelling to Advance Signite Technology
    BCF Requests Greater Urgency on REACH Impasse
    Updated Method Published for Entire BASF Product Portfolio
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ACTEGA teams with Makro Labelling to advance Signite technology
    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mann+Hummel Names President Air Filtration Americas
    KNH Launches Eco-Friendly Menstrual Pads
    Niine Introduces India's First PLA-Based Sanitary Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Enrollment Completed in Anika Therapeutics' Hyalofast Study
    Exactech Releases Next-Gen GPS Shoulder
    Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Presents Path to Accelerate Revenue Growth
    STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
    Graphene Flagship to Join Euro Nano Forum 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login